Who is the CEO of Fabtech Technologies Ltd?
- Answer Field
-
The Chief Executive Officer of Fabtech Technologies Ltd is Ashwani Kumar Singh.
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company that specialises in delivering turnkey projects for the pharmaceutical, biotechnology, and healthcare sectors. The company offers end-to-end services, including design, engineering, manufacturing, installation, and project management, with expertise in cleanroom technology, HVAC systems, and process equipment. Fabtech provides solutions for the entire bio-pharma manufacturing lifecycle, covering greenfield projects from initial planning and design to market-ready products. Its services include clean water and clean air solutions, supporting industries such as life sciences, food and beverage, IT, semiconductor, and aeronautics.
Headquartered in India, Fabtech has a global presence spanning over 62 countries, including key emerging economies such as Bangladesh, Egypt, Ethiopia, Kenya, Morocco, Nigeria, South Africa, Turkey, UAE, and the USA. As of July 31, 2025, the company employed 185 permanent staff. Leveraging its technical expertise and infrastructure, Fabtech provides comprehensive solutions for establishing aseptic manufacturing facilities, handling all aspects from project planning, procurement, and quality assurance to installation, commissioning, and certification..
For more details, visit the Fabtech Technologies IPO page.
Details | Information |
IPO Date | September 29, 2025 to October 1, 2025 |
Issue Size | 1,20,60,000 shares (aggregating up to ₹230.35 Cr) |
Price Band | ₹181 to ₹191 per share |
Lot Size | 75 shares |
Listing At | NSE BSE |
Funding working capital requirements of the Company.
Pursuing inorganic growth initiatives through acquisitions.
General Corporate Purposes.
Event | Date |
---|---|
IPO Open Date | Mon, Sep 29, 2025 |
IPO Close Date | Wed, Oct 1, 2025 |
Tentative Allotment | Fri, Oct 3, 2025 |
Initiation of Refunds | Mon, Oct 6, 2025 |
Credit of Shares to Demat | Mon, Oct 6, 2025 |
Tentative Listing Date | Tue, Oct 7, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on Wed, Oct 1, 2025 |
₹181 to ₹191 per share
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 75 | ₹14,325 |
Retail (Max) | 13 | 975 | ₹1,86,225 |
S-HNI (Min) | 14 | 1,050 | ₹2,00,550 |
S-HNI (Max) | 69 | 5,175 | ₹9,88,425 |
B-HNI (Min) | 70 | 5,250 | ₹10,02,750 |
Log in to Your Trading Account
Access your trading account through your broker’s platform.
Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Select Fabtech Technologies IPO
Find "Fabtech Technologies IPO" and click on the ‘Apply’ button.
Enter Application Details
Specify the number of lots (minimum lot size: 75 shares) and the bid price within the range of ₹181 to ₹191 per share.
Provide Your UPI ID
Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit
Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on Oct 1, 2025, to complete your application process.
Additional Read- How to Apply for the Fabtech Technologies IPO?
Total Assets: Grew from ₹213.86 crore in FY23 to ₹426.56 crore as of March 2025.
Total income: Reached ₹335.94 crore in FY25.
Profit After Tax (PAT): Stood at ₹46.45 crore for March 2025.
Net Worth: Recorded at ₹173.11 crore in FY25.
Reserves and Surplus: Recorded at ₹140.72 crore (March 2025), growing steadily over the years.
EBITDA: Stood at ₹47.28 crore in March 2025.
The company has shown steady growth in total assets over the past few years, reflecting expansion in its operations and investments.
Revenue generation has increased consistently, indicating a strengthening business and growing client base.
Profitability has improved over time, demonstrating operational efficiency and effective cost management.
Shareholder equity and net worth have grown, reflecting a solid financial foundation and retained earnings.
Reserves and surplus have increased steadily, supporting future growth initiatives and business sustainability.
Operational performance, as reflected in earnings before interest, taxes, depreciation, and amortisation, indicates stable and efficient business operations.
Overall, the company’s financial performance and strategic initiatives point to positive growth prospects and a capacity to support its expansion in domestic and international markets.
The company’s growth and profitability are linked to the pharmaceutical and biotech sectors, which are subject to regulatory changes and compliance requirements that could affect operations.
Expansion into international markets and emerging economies carries risks related to geopolitical factors, foreign exchange fluctuations, and differing business environments.
Fabtech’s turnkey solutions, covering design, engineering, cleanroom technology, and project management, position it to benefit from increasing demand for pharmaceutical and biotech infrastructure.
The company’s global footprint across more than 60 countries, combined with rising investments in greenfield and modular facilities, presents opportunities for business expansion and long-term growth.
KPI | Values |
ROE | 30.46% |
ROCE | 24.46% |
Debt/Equity | 0.32 |
RoNW | 26.83% |
PAT Margin | 13.83% |
EBITDA Margin | 14.07% |
Price to Book Value | 3.57 |
Registrar | Lead Manager(s) |
---|---|
Bigshare Services Pvt.Ltd. | Unistone Capital Pvt.Ltd. |
Fabtech Technologies Ltd 715, Janki Centre, Off. Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053
Phone: +91 226 159 2900
Email: cs@fabtechnologies.com
Website: http://www.fabtechnologies.com/
Fabtech Technologies Ltd operates as a biopharma engineering company providing turnkey solutions for the pharmaceutical, biotechnology, and healthcare sectors. Its services include design, engineering, cleanroom systems, and project management, covering the full manufacturing lifecycle from planning to commissioning. The company maintains a global presence across multiple countries and manages operations in both emerging and developed markets.
The IPO proceeds are intended for working capital requirements, inorganic growth through acquisitions, and general corporate purposes. The company has shown steady growth in assets, income, and reserves over the past few years, with operational performance indicating a stable business environment and capacity to support ongoing activities.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Fabtech Technologies IPO.
Share this article:
No result found
The Chief Executive Officer of Fabtech Technologies Ltd is Ashwani Kumar Singh.
The IPO is scheduled to open on September 29, 2025, and close on October 1, 2025.
Fabtech Technologies Ltd operates in the biopharma engineering sector, providing turnkey solutions for pharmaceutical, biotechnology, and healthcare facilities. Its model involves design, engineering, cleanroom technology, and project management across multiple countries, which allows it to cater to both emerging and developed markets. Sustainability depends on regulatory compliance, operational efficiency, and continued demand for bio-pharma infrastructure.
The issue size is 1,20,60,000 shares, aggregating up to ₹230.35 crore.
‘Pre-apply’ allows investors to submit their application before the IPO opens so that the order is queued and ready once the IPO subscription begins.
Confirmation of order placement is typically available immediately after submission through the trading platform or broker used for the application.
The minimum lot size is 75 shares. Retail investors can apply for one or more lots, with each lot representing 75 shares.
The tentative allotment date is October 3, 2025.
The registrar for the IPO is Bigshare Services Pvt. Ltd.
Based on publicly available information, there are no governance concerns or red flags reported regarding the company’s leadership or board structure.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading